Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2006-11-6
pubmed:abstractText
Although the considerable progress against gastric cancer, it remains a complex lethal disease defined by peculiar histological and molecular features. The purpose of the present study was to investigate pRb2/p130, VEGF, EZH2, p53, p16(INK4A), p27(KIP1), p21(WAF1), Ki-67 expressions, and analyze their possible correlations with clinicopathological factors. The expression patterns were examined by immunohistochemistry in 47 patients, 27 evaluated of intestinal-type, and 20 of diffuse-type, with a mean follow up of 56 months and by Western blot in AGS, N87, KATO-III, and YCC-2, -3, -16 gastric cell lines. Overall, stomach cancer showed EZH2 correlated with high levels of p53, Ki-67, and cytoplasmic pRb2/p130 (P < 0.05, and P < 0.01, respectively). Increased expression of EZH2 was found in the intestinal-type and correlated with the risk of distant metastasis (P < 0.05 and P < 0.01, respectively), demonstrating that this protein may have a prognostic value in this type of cancer. Interestingly, a strong inverse correlation was observed between p27(KIP1) expression levels and the risk of advanced disease and metastasis (P < 0.05), and a positive correlation between the expression levels of p21(WAF1) and low-grade (G1) gastric tumors (P < 0.05), confirming the traditionally accepted role for these tumor-suppressor genes in gastric cancer. Finally, a direct correlation was found between the expression levels of nuclear pRb2/p130 and low-grade (G1) gastric tumors that was statistically significant (P < 0.05). Altogether, these data may help shed some additional light on the pathogenetic mechanisms related to the two main gastric cancer histotypes and their invasive potentials.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/CDKN1A protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Cyclin-Dependent Kinase Inhibitor..., http://linkedlifedata.com/resource/pubmed/chemical/Cyclin-Dependent Kinase Inhibitor..., http://linkedlifedata.com/resource/pubmed/chemical/Cyclin-Dependent Kinase Inhibitor..., http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins, http://linkedlifedata.com/resource/pubmed/chemical/EZH2 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Ki-67 Antigen, http://linkedlifedata.com/resource/pubmed/chemical/Retinoblastoma-Like Protein p130, http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factors, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53, http://linkedlifedata.com/resource/pubmed/chemical/VEGFA protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0021-9541
pubmed:author
pubmed:issnType
Print
pubmed:volume
210
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
183-91
pubmed:dateRevised
2007-5-2
pubmed:meshHeading
pubmed-meshheading:16998811-Aged, pubmed-meshheading:16998811-Aged, 80 and over, pubmed-meshheading:16998811-Blotting, Western, pubmed-meshheading:16998811-Cell Line, Tumor, pubmed-meshheading:16998811-Cyclin-Dependent Kinase Inhibitor p16, pubmed-meshheading:16998811-Cyclin-Dependent Kinase Inhibitor p21, pubmed-meshheading:16998811-Cyclin-Dependent Kinase Inhibitor p27, pubmed-meshheading:16998811-DNA-Binding Proteins, pubmed-meshheading:16998811-Female, pubmed-meshheading:16998811-Follow-Up Studies, pubmed-meshheading:16998811-Humans, pubmed-meshheading:16998811-Immunohistochemistry, pubmed-meshheading:16998811-Intestinal Neoplasms, pubmed-meshheading:16998811-Ki-67 Antigen, pubmed-meshheading:16998811-Male, pubmed-meshheading:16998811-Middle Aged, pubmed-meshheading:16998811-Neoplasm Invasiveness, pubmed-meshheading:16998811-Prognosis, pubmed-meshheading:16998811-Proportional Hazards Models, pubmed-meshheading:16998811-Retinoblastoma-Like Protein p130, pubmed-meshheading:16998811-Stomach Neoplasms, pubmed-meshheading:16998811-Transcription Factors, pubmed-meshheading:16998811-Tumor Markers, Biological, pubmed-meshheading:16998811-Tumor Suppressor Protein p53, pubmed-meshheading:16998811-Vascular Endothelial Growth Factor A
pubmed:year
2007
pubmed:articleTitle
Immunohistochemical analysis of pRb2/p130, VEGF, EZH2, p53, p16(INK4A), p27(KIP1), p21(WAF1), Ki-67 expression patterns in gastric cancer.
pubmed:affiliation
Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania 19122, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural